Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PMN
PMN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PMN News
ProMIS Neurosciences to Participate in Multiple Upcoming Conferences
May 28 2026
Newsfilter
ProMIS Neurosciences Reports Q1 2026 Financial Results
May 12 2026
seekingalpha
ProMIS Secures $175 Million Financing to Support Alzheimer's Clinical Trial
May 12 2026
Newsfilter
Promis Neurosciences Plans to Raise $200M
Mar 26 2026
seekingalpha
ProMIS Neurosciences Reports 2025 Financial Results and Pipeline Updates
Mar 26 2026
NASDAQ.COM
PROMIS NEUROSCIENCES INC MAY ISSUE SECURITIES WORTH UP TO $200 MILLION, ACCORDING TO SEC FILING
Mar 25 2026
moomoo
ProMIS Neurosciences Reports FY Losses Exceeding Expectations
Mar 25 2026
seekingalpha
PROMIS NEUROSCIENCES RELEASES 2025 FULL YEAR FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
Mar 25 2026
moomoo
Phoenix Mecano Valued at CHF 769, Currently 44% Undervalued
Jan 18 2026
Yahoo Finance
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Dec 19 2025
NASDAQ.COM
After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences
Dec 09 2025
NASDAQ.COM
ProMIS Neurosciences CEO to Participate in Evercore Healthcare Conference on December 2, 2025
Dec 01 2025
Globenewswire
Dow Rises by 300 Points; Waldencast Stock Takes a Dive
Nov 24 2025
Benzinga
Nasdaq Rises by 350 Points; Enlivex Therapeutics Stock Jumps Significantly
Nov 24 2025
Benzinga
HC Wainwright & Co. Affirms Buy Rating for ProMIS Neurosciences, Keeps $4 Price Target Intact
Nov 21 2025
Benzinga
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
Sep 18 2025
PRnewswire
Show More News
